These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 7059063)

  • 21. Polymorphism of apolipoprotein E. II. Genetics of hyperlipoproteinemia type III.
    Utermann G; Vogelberg KH; Steinmetz A; Schoenborn W; Pruin N; Jaeschke M; Hees M; Canzler H
    Clin Genet; 1979 Jan; 15(1):37-62. PubMed ID: 215360
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Genetic aspects of primary atherogenic dyslipoproteinemia].
    Turpin G; Bruckert E
    C R Seances Soc Biol Fil; 1995; 189(5):905-17. PubMed ID: 8673636
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of fenofibrate on apolipoprotein kinetics in patients with coexisting dysbetalipoproteinemia and heterozygous familial hypercholesterolemia.
    Tremblay AJ; Lamarche B; Ruel IL; Hogue JC; Deshaies Y; Gagné C; Couture P
    Atherosclerosis; 2006 Sep; 188(1):203-12. PubMed ID: 16337207
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Apolipoprotein and lipid composition of plasma lipoproteins in neonates during the first month of life.
    van Biervliet JP; Rosseneu M; Bury J; Caster H; Stul MS; Lamote R
    Pediatr Res; 1986 Apr; 20(4):324-8. PubMed ID: 3085061
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structural peculiarities of the binding of very low density lipoproteins and low density lipoproteins to the LDL receptor in hypertriglyceridemia: role of apolipoprotein E.
    Dergunov AD; Smirnova EA; Merched A; Visvikis S; Siest G; Yakushkin VV; Tsibulsky V
    Biochim Biophys Acta; 2000 Feb; 1484(1):29-40. PubMed ID: 10685028
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Apolipoprotein E phenotype frequency in type II diabetic patients with different forms of hyperlipoproteinemia.
    Parhofer KG; Richter WO; Schwandt P
    Horm Metab Res; 1990 Nov; 22(11):589-94. PubMed ID: 2272605
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Apolipoproteins A-I, A-II and E as well as high density lipoproteins in blood of persons with dis-alpha-lipoproteinemias].
    Denisenko AD; Usatenko MS; Lozovskiĭ VT; Triufanov VF; Oleĭnik IA
    Vopr Med Khim; 1981; 27(2):272-80. PubMed ID: 6792777
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The pathogenesis and clinical significance of xanthelasma palpebrarum.
    Bergman R
    J Am Acad Dermatol; 1994 Feb; 30(2 Pt 1):236-42. PubMed ID: 8288783
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Apolipoprotein E (role in lipoprotein metabolism and pathophysiology of hyperlipoproteinemia type III).
    Utermann G
    Ric Clin Lab; 1982; 12(1):23-30. PubMed ID: 6283616
    [No Abstract]   [Full Text] [Related]  

  • 30. [Xanthoma and atherosclerosis in the presence of normal plasma lipids].
    Davignon J; Bouthillier D; Dufour R; Lussier-Cacan S
    Ann Med Interne (Paris); 1983; 134(5):483-91. PubMed ID: 6651070
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Apolipoprotein C-III(Lys58----Glu). Identification of an apolipoprotein C-III variant in a family with hyperalphalipoproteinemia.
    von Eckardstein A; Holz H; Sandkamp M; Weng W; Funke H; Assmann G
    J Clin Invest; 1991 May; 87(5):1724-31. PubMed ID: 2022742
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular variants of the lipoproteins.
    Galton DJ; Stocks J; Rees A
    Clin Sci (Lond); 1983 Jun; 64(6):559-63. PubMed ID: 6404583
    [No Abstract]   [Full Text] [Related]  

  • 33. Characterization of lipoproteins containing a truncated form of apolipoprotein B, apolipoprotein B32.
    McCormick SP; Day WA; George PM
    Biochim Biophys Acta; 1995 Aug; 1258(1):49-56. PubMed ID: 7654780
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Familial dysbetalipoproteinemia. New aspects of pathogenesis and diagnosis.
    Havel RJ
    Med Clin North Am; 1982 Mar; 66(2):441-54. PubMed ID: 7040846
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Different mobility in SDS--polyacrylamide gel electrophoresis of apolipoprotein E from phenotypes apo E-N and Apo E-D.
    Utermann G; Weber W; Beisiegel U
    FEBS Lett; 1979 May; 101(1):21-6. PubMed ID: 221251
    [No Abstract]   [Full Text] [Related]  

  • 36. Measurement of very low density and low density lipoprotein apolipoprotein (Apo) B-100 and high density lipoprotein Apo A-I production in human subjects using deuterated leucine. Effect of fasting and feeding.
    Cohn JS; Wagner DA; Cohn SD; Millar JS; Schaefer EJ
    J Clin Invest; 1990 Mar; 85(3):804-11. PubMed ID: 2107210
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Biochemical diagnosis of hereditary hyperlipoproteinemias].
    Tvorogova MG; Rozhkova TA; Alidzhanova KhG; Semenova OA; Sobolev AV; Kukharchuk VV; Titov VN
    Ter Arkh; 1998; 70(4):9-15. PubMed ID: 9612894
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Isolation and characterization of apolipoprotein B-48 and B-100 very low density lipoproteins from type III hyperlipoproteinemic subjects.
    Milne RW; Weech PK; Blanchette L; Davignon J; Alaupovic P; Marcel YL
    J Clin Invest; 1984 Mar; 73(3):816-23. PubMed ID: 6368590
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of apolipoprotein E phenotype on plasma lipids and lipoproteins in alcohol abusers.
    Liinamaa MJ; Kervinen K; Hannuksela ML; Kesäniemi YA; Savolainen MJ
    Alcohol Clin Exp Res; 1997 Jun; 21(4):606-12. PubMed ID: 9194912
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization and metabolic fate of two very-low-density lipoprotein subfractions separated by heparin-sepharose chromatography.
    Huff MW; Telford DE
    Biochim Biophys Acta; 1984 Dec; 796(3):251-61. PubMed ID: 6509076
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.